Schedule 13G ownership disclosure
REVANCE THERAPEUTICS INC
Security class unavailable · CUSIP: 761330109
Event date: 2015-11-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-15-000576
- Form type
- SC 13G
- Filer
- JPMORGAN CHASE & CO
- CIK
- CIK 19617
- Filed
- Dec 07, 2015
- Reporting period
- Nov 30, 2015
- Description
- Schedule 13G beneficial ownership